踝下修饰因子P0/P1对慢性肢体威胁性缺血患者旁路手术与血管内治疗伤口愈合的影响
回顾性多中心分析2015至2022年因慢性肢体威胁性缺血行腹股沟下血运重建的患者,比较踝下P0与P1对旁路手术与血管内治疗伤口愈合的影响。P1队列中旁路手术1年伤口愈合率86.2% vs 血管内治疗66.2%(P<.001),2年保肢率91.8% vs 81.5%(P=.004);P0队列两组无显著差异。
要点
- 踝下P1患者旁路手术1年伤口愈合率86.2% vs 血管内治疗66.2%(P<.001)。
- 踝下P1患者旁路手术2年保肢率91.8% vs 血管内治疗81.5%(P=.004)。
- 踝下P0患者两组伤口愈合与保肢率均无显著差异。
核心结论
- 踝下P1患者旁路手术的伤口愈合和保肢优于血管内治疗,踝下P0患者两组无差异。
- 作者认为对有组织缺损且踝下P1病变的患者,旁路手术应被视为优于血管内治疗的血运重建策略。
研究设计与样本
- 回顾性分析2015至2022年因慢性肢体威胁性缺血行腹股沟下血运重建的多中心数据。
- 倾向性评分匹配后踝下P0队列66对,踝下P1队列189对。
主要发现
- 踝下P0队列1年伤口愈合率旁路手术94.5% vs 血管内治疗85.7%(P=.092)。
- 踝下P1队列1年伤口愈合率旁路手术86.2% vs 血管内治疗66.2%(P<.001)。
- 踝下P0队列2年保肢率旁路手术96.7% vs 血管内治疗94.1%(P=.625)。
- 踝下P1队列2年保肢率旁路手术91.8% vs 血管内治疗81.5%(P=.004)。
- 踝下P0和P1队列中旁路手术与血管内治疗的术后并发症率均无显著差异。
关键数值与推荐
- 踝下P表示目标动脉跨入足部,足背弓完整为P0,足背弓缺失或严重病变为P1。
- 终点为伤口愈合、保肢和术后并发症。
临床怎么用
- 作者认为对有组织缺损且踝下P1病变的患者,旁路手术应被视为优于血管内治疗的血运重建策略。
- 踝下P0患者旁路手术与血管内治疗在伤口愈合和保肢方面无差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study aimed to compare the influence of inframalleolar (IM) P0/P1 on wound healing in bypass surgery vs endovascular therapy (EVT) in patients with chronic limb-threatening ischemia (CLTI). METHODS: We retrospectively analyzed the multicenter data of patients who underwent infra-inguinal revascularization for CLTI between 2015 and 2022. IM P represents target artery crossing into foot, with intact pedal arch (P0) and absent or severely diseased pedal arch (P1). The endpoints were wound healing, limb salvage (LS), and postoperative complications. RESULTS: We analyzed 66 and 189 propensity score-matched pairs in the IM P0 and IM P1 cohorts, respectively. In the IM P0 cohort, the 1-year wound healing rates were 94.5% and 85.7% in the bypass surgery and EVT groups, respectively (P = .092), whereas those in the IM P1 cohort were 86.2% and 66.2% in the bypass surgery and EVT groups, respectively (P < .001). In the IM P0 cohort, the 2-year LS rates were 96.7% and 94.1% in the bypass surgery and EVT groups, respectively (P = .625), and those in the IM P1 cohort were 91.8% and 81.5% in the bypass surgery and EVT groups, respectively (P = .004). No significant differences were observed between the bypass surgery and EVT in terms of postoperative complication rates in either the IM P0 or P1 cohorts. CONCLUSIONS: Bypass surgery facilitated better wound healing and LS than EVT in patients with IM P1. Conversely, no differences in wound healing or LS were observed between groups in patients with IM P0. Bypass surgery should be considered a better revascularization strategy than EVT in patients with tissue loss and IM P1 disease.
引用
- Morisaki K, Matsuda D, Guntani A, et al. Influence of inframalleolar modifier P0/P1 on wound healing in bypass surgery vs endovascular therapy in patients with chronic limb-threatening ischemia. J Vasc Surg. 2024. PMID: 38649101. doi:10.1016/j.jvs.2024.04.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。